TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Nordic Biomarker AB
Closing information (x1000 SEK)
Closing information | 2022/12 | 2021/12 (consolidated) | 2020/12 (consolidated) |
Turnover | 129,627 | 130,741 | 108,946 |
Financial expenses | 1,804 | 391 | 397 |
Earnings before taxes | -25,311 | -10 | 13,290 |
EBITDA | -14,454 | 11,996 | 22,572 |
Total assets | 208,098 | 173,830 | 158,445 |
Current assets | 71,014 | 73,201 | 73,028 |
Current liabilities | 71,158 | 36,838 | 28,990 |
Equity capital | 135,293 | 99,206 | 102,209 |
- share capital | 150 | 150 | 150 |
Employees (average) | 75 | 66 | 56 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 (consolidated) | 2020/12 (consolidated) |
Solvency | 65.0% | 57.1% | 64.5% |
Turnover per employee | 1,728 | 1,981 | 1,945 |
Profit as a percentage of turnover | -19.5% | 0.0% | 12.2% |
Return on assets (ROA) | -11.3% | 0.2% | 8.6% |
Current ratio | 99.8% | 198.7% | 251.9% |
Return on equity (ROE) | -18.7% | 0.0% | 13.0% |
Change turnover | |||
Change turnover % | 20% | ||
Chg. No. of employees | |||
Chg. No. of employees % | 18% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 (consolidated) | 2020/12 (consolidated) |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.